A Phase IB Study of Crizotinib in Combi

Project: Research project

Description

A Phase IB Study of Crizotinib in Combination with Pembrolizumab (MK-3475) in Patients with Untreated Advanced ALK-Translocated Non-Small Cell Lung Cancer
StatusActive
Effective start/end date11/20/157/30/20

Funding

  • PFIZER, INC.

Fingerprint

Non-Small Cell Lung Carcinoma
crizotinib
pembrolizumab